Khatija A.

• First and foremost, treating cancer locally. • Cultivate, establish, and nurture robust connections with both existing and potential investors. Identify and cultivate relationships with high-net-worth individuals, family offices and foundations. Secure capital with an astute grasp of the company’s financial projections, strategic plans, business expansion, investor interactions and intellectual property landscape. • Build trust relations with key partners and stakeholders and act as a point of contact for important shareholders and key opinion leaders from Centers of Excellence around the world. • Define precise performance metrics across all business facets, including technology, product development, marketing and more. Oversee and evaluate the progress and accomplishments of the product against these benchmarks.

• Provide diligence on biotech & scientific assets for the GCC region • Custom build strong executable strategies

• Perform in-depth primary research within the life science sector, extracting insights from data and producing comprehensive documents and presentations while effectively communicating findings and results.

• Formulate robust business strategies and plans of the highest caliber to guarantee coherence with both short-term and long-term goals while providing strategic guidance to pharmaceutical enterprises and sizable non-profit entities.

• Oversaw the pediatric therapeutic pipeline across North America encompassing more than 100 assets, concurrently directing a skilled team of 8 professionals. • Performed comprehensive due diligence on prospective investments, skillfully articulating findings to the investment committee. • Played an integral role in nurturing investor relations and facilitating capital formation endeavors within the United States and Canada.

• Spearheaded comprehensive due diligence activities across the entire investment lifecycle, spanning from early to late-stage life science assets.

• Spearheaded comprehensive due diligence activities across the entire investment lifecycle, spanning from early to late-stage life science assets. • Orchestrated a strategic focus on gene-editing and gene therapy assets, contributing from initial discovery to the clinical trial phase. Formulated cohesive business, nonclinical and clinical strategies. • Formulated and executed a visionary joint venture in collaboration with prominent pharmaceutical corporations and renowned academic institutions. • Engaged actively in investment initiatives, intricate valuation exercises and the meticulous art of risk management.

• Orchestrated a successful spin-out of a Phase II biological asset, encompassing the creation of comprehensive business and clinical development strategies. Secured funding amounting to $20M through a Series A funding round. • Held a pivotal client-facing role, conducting scientific due diligence encompassing of primary and secondary research. Activities spanned competitor analyses, literature reviews, and scientific evaluations of both early and late-stage biotech assets. • Executed in-depth primary research, proficiently translating findings into documents and presentations. • Nurtured strategic relationships, encompassing both transactional and non-transactional interactions.

• Performed comprehensive due diligence, data analysis and strategic evaluations encompassing the entire lifecycle of a biotech asset, spanning from discovery to commercial viability. Engaged in the scouting and meticulous assessment of diverse biotech and life science assets. • Played a vital role in preparing and delivering presentations, particularly within the sphere of industry thought leadership contributing valuable insights and expertise.

• Educated both graduate and undergraduate students in 3rd-year Anatomy and Physiology courses, delivering engaging and comprehensive lessons. • Strategically designed and crafted lectures, facilitated interactive in-class discussions, and formulated challenging assignments. • Evaluated student performance based on criteria including participation, in-class accomplishments, assignments, and examinations, subsequently assigning grades. • Generated comprehensive reports on student learning outcomes, compiled class feedback reviews, and meticulously analyzed student data.

• Instructed courses in Immunology, Anatomy and Physiology, employing a diverse range of teaching methods including lectures, weekly quizzes, examinations and interactive group discussions. • Contributed to curriculum development, writing and continuous updates to ensure the relevance and efficacy of educational content. • Documented student progress and performance evaluations, offering personalized advice and devising study plans tailored to individual needs. • Played a pivotal role in supporting and preparing OUM students for the USMLE examinations while facilitating their successful course completion.

• Managed the complete lifecycle of data, including collection, entry, verification, maintenance, analysis and reporting, ensuring data integrity and accuracy. • Utilized specialized statistical software like SPSS to conduct data analysis and interpret findings, contributing to informed decision-making. • Devised, established, and upheld databases, data collection forms, error validation techniques, and associated programs, streamlining the process of data collection, analysis and reporting

• Managed and upheld project databases, entailing responsibilities like drafting protocols and submitting requests to the Research Ethics Board (REB). • Orchestrated participant recruitment by devising schedules and conducting screenings, ensuring the optimal enrollment of patients. • Efficiently supervised the collection and organization of study-related data, including meticulous review of transcripts to guarantee high-quality collection. • Acted as a liaison between research coordinators both internally and externally, foresting seamless collaboration. • Assured the proper documentation of data, overseeing the physical and digital storage of records in alignment with hospital protocols and pertinent privacy regulations.